Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides type.
about
Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial.The potential of combi-molecules with DNA-damaging function as anticancer agents.Synthesis and Antitumor Activity Evaluation of a Novel Combi-nitrosourea Prodrug: BGCNU.Altering Residue 134 Confers an Increased Substrate Range of Alkylated Nucleosides to the E. coli OGT Protein.[Treatment of mycosis fungoides and Sézary syndrome].
P2860
Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides type.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Phase I clinical trial of O6-b ...... phoma, mycosis fungoides type.
@ast
Phase I clinical trial of O6-b ...... phoma, mycosis fungoides type.
@en
type
label
Phase I clinical trial of O6-b ...... phoma, mycosis fungoides type.
@ast
Phase I clinical trial of O6-b ...... phoma, mycosis fungoides type.
@en
prefLabel
Phase I clinical trial of O6-b ...... phoma, mycosis fungoides type.
@ast
Phase I clinical trial of O6-b ...... phoma, mycosis fungoides type.
@en
P2093
P2860
P1433
P1476
Phase I clinical trial of O6-b ...... phoma, mycosis fungoides type.
@en
P2093
Anita C Gilliam
Derek V Chan
Gary S Wood
Kevin D Cooper
Narin Apisarnthanarax
Sarolta K Szabo
Scot C Remick
Sean Carlson
P2860
P304
P356
10.1001/ARCHDERMATOL.2011.2797
P577
2012-05-01T00:00:00Z